Abiomed’s Impella® Technology Showcased at TCT 2013 With Over 25 Accepted Presentations in the Scientific Sessions

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DANVERS, Mass., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Abiomed Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, notes that there will be over 25 potential Impella presentations in the scientific sessions at the Cardiovascular Research Foundation’s (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific meeting, scheduled from October 27 – November 1, at the Moscone Convention Center in San Francisco, CA.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC